anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

193,381-193,440 of 319,975

filter-aware
06
The slide uses a comparison frame to illustrate the mechanism of action for the drug candidate.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
07
The slide outlines a 28-day treatment period with daily administration, targeting Friedreich's ataxia patients.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Roadmap1 hit
08
FA likely refers to Friedreich's Ataxia; FXN refers to frataxin protein.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
09
The slide uses a process flow diagram to show the relationship between SAD and MAD trials.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
10
The slide details the dosing schedule (13 days) and specific sampling days for buccal cells, skin, and platelets across three cohorts with different dosages.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
11
The slide displays two dot plots with error bars representing median and 25th/75th percentiles for different dose cohorts over time.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
12
The chart displays a longitudinal study of FXN concentration across different dose groups (Placebo, 25mg, 50mg, 100mg) at Baseline, Day 4/7, and Day 13.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
13
The slide uses a two-part structure to address clinical safety and non-clinical toxicology findings.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
14
The slide uses a horizontal layout with four distinct trial descriptions, each paired with an icon.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
15
The slide uses a simple three-row layout to summarize the drug's purpose, current data status, and future milestones.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
16
Larimar Therapeutics | Investor Presentation Deck | 32 slidesLarimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
17
Larimar Therapeutics | Investor Presentation Deck | 32 slidesLarimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
18
Larimar Therapeutics | Investor Presentation Deck | 32 slidesLarimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
19
Standard clinical trial demographic table.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
20
Clinical trial data table showing age at onset, age at diagnosis, and assistive device usage.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
21
The slide displays two dot plots with error bars representing median and 25th/75th percentiles.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
22
The slide presents two dot plots with error bars representing median and 25th/75th percentiles for FXN concentration and change from baseline.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
23
Larimar Therapeutics | Investor Presentation Deck | 32 slidesLarimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
24
The slide uses a standard corporate team bio layout with 10 members arranged in two rows of five.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
25
The slide serves as a credibility-building asset by showcasing alignment with a key patient advocacy group.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
26
The slide presents the Scientific Advisory Board members with headshots and brief professional biographies.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
27
The slide uses a two-column list format to contrast cardiac and neurologic study outcomes.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
28
Kaplan-Meier survival curve showing significant separation between treatment and vehicle groups.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
29
The slide uses a bulleted list with checkmarks to summarize key findings from a specific mouse model study.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
30
Data shows functional replacement of hFXN and normalization of gene expression.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
31
Data presented as line charts with error bars, comparing KO: CTI-1601, KO: Vehicle, and Wild-type: Vehicle.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
32
Data presented as line charts showing percent change over time (weeks 4 and 8) for Ejection Function and Fractional Shortening.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
01
Slide 1
Limbach Holdings | Investor Presentation Deck | 25 slidesLimbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
02
Limbach Holdings | Investor Presentation Deck | 25 slidesLimbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
03
The slide provides a snapshot of the company's identity, services, competitive differentiation, and financial health as of late 2022.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Beat · ProblemLoop · Logic Chain1 hit
04
The slide uses a linear process diagram to map services to business outcomes.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
05
The slide uses a comparison framework to contrast the two business models, highlighting the shift toward higher-margin ODR services.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Beat · Market SizeLoop · Logic Chain1 hit
06
The slide uses a structured list format to present investment thesis points.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Loop · Logic Chain1 hit
07
Uses a structured 4-column framework to present a client success story.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
08
The slide uses a quadrant-based layout to summarize business operations.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
09
The slide emphasizes resilience and adaptability over a 120-year period.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
10
ODR likely stands for Owner Direct Revenue or similar.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
11
The slide uses a list-based layout to present strategic initiatives.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
12
TTM = Trailing Twelve Months; ODR = Owner Direct Revenue (implied context).Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
GCR likely stands for General Contractor/Construction Revenue; ODR likely stands for Owner-Direct Revenue.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
The slide uses a map to visualize target geographies for acquisition alongside strategic pillars and criteria.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
15
The slide uses callouts to explicitly link current performance metrics to future expectations.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
16
The slide uses a 2x3 grid layout to present six key investment pillars.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
17
Includes a footnote regarding the reconciliation of Adjusted EBITDA.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
18
Limbach Holdings | Investor Presentation Deck | 25 slidesLimbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
19
Includes year-over-year percentage change indicators for each metric.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
20
The slide uses stacked bar charts to show segment contributions (GCR vs ODR) and highlights year-over-year percentage changes.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
21
The table highlights a reduction in net debt and total debt over the six-month period.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
22
Limbach Holdings | Investor Presentation Deck | 25 slidesLimbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
23
Includes detailed breakdown of non-GAAP adjustments such as depreciation, stock-based compensation, and restructuring costs.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
24
Includes detailed footnotes regarding non-GAAP financial measures and specific calculation methodologies.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
25
Limbach Holdings | Investor Presentation Deck | 25 slidesLimbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
01
Slide 1
Limoneira | Investor Presentation Deck | 39 slidesLimoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Situation & Context1 hit
02
Limoneira | Investor Presentation Deck | 39 slidesLimoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Situation & Context1 hit
03
Limoneira | Investor Presentation Deck | 39 slidesLimoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Situation & Context1 hit
04
The slide uses a grid-based layout to categorize assets into three main pillars: Agricultural Land/Water, Business Venture, and Real Estate.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Situation & Context1 hit
05
Limoneira | Investor Presentation Deck | 39 slidesLimoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Problem & Complication1 hit
06
Limoneira | Investor Presentation Deck | 39 slidesLimoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Problem & Complication1 hit
07
Limoneira | Investor Presentation Deck | 39 slidesLimoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Problem & Complication1 hit
08
The slide uses a circular flow diagram to represent a self-reinforcing business cycle.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Problem & Complication1 hit